ベータ
治験レーダーAI

AstraZeneca が主要治験依頼者または共同研究者として関与する治験について話し合い、探索しましょう。

場所 ハンガリー に一致する糖尿病の治験(臨床試験)を表示しています。

健康状態や治療法を理解し、近くの治験を探すお手伝いができます。
私たちの検索ツールは英語のみをサポートしています。他の言語で検索と議論するには、上の治験レーダーを使用するか、以下の疾患と場所のフィルターを選択してください。
48 結果
  
疾患名
糖尿病
×
 
場所
ハンガリー
×
 
種類
医薬品
×
 
試験タイトル
状況
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus NCT02229383
完了結果公開
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo NCT02229396
完了結果公開
2型糖尿病の成人におけるAZD5004の1日1回経口投与の有効性、安全性、および耐容性に関する研究（26週間） (SOLSTICE) NCT06579105
完了
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone NCT02419612
完了結果公開
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise NCT00327015
完了結果公開
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients NCT01020123
完了結果公開
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease (PLANET 1) NCT00296374
完了結果公開
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus (THEMIS) NCT01991795
完了結果公開
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin (GENERATION) NCT01006603
完了結果公開
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1) NCT02268214
完了結果公開
Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus NCT00885378
完了結果公開
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus NCT01144338
完了結果公開
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications (SAVOR- TIMI 53) NCT01107886
完了結果公開
Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes NCT00855166
完了結果公開
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes NCT00516048
完了結果公開
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin NCT02551874
完了結果公開
Exenatide Versus Glimepiride in Patients With Type 2 Diabetes NCT00359762
完了結果公開
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) NCT00676338
完了結果公開
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes NCT01029886
完了結果公開
Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy NCT00099619
完了
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) NCT00641056
完了結果公開
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination NCT00044668
完了
GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes NCT00252876
中止
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years NCT02725593
完了結果公開
GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes NCT00300105
中止
Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin NCT00673231
完了結果公開
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes NCT01619059
完了結果公開
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients NCT00680745
完了結果公開
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone NCT02284893
完了結果公開
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure (MEASURE-HF) NCT02917031
完了結果公開
Evaluation of Dapagliflozin Taken Twice-daily NCT01217892
完了結果公開
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea NCT02471404
完了結果公開
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication NCT01195662
完了結果公開
Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment NCT00614939
完了結果公開
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker NCT01137474
完了結果公開
GALLANT 4 Tesaglitazar vs. Glibenclamide NCT00255541
中止
Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin NCT00757588
完了結果公開
GALLANT 22 Tesaglitazar vs. Placebo NCT00252837
中止
52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period NCT00575588
完了結果公開
GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate NCT00261352
中止
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI (PRECISE) NCT02370537
完了結果公開
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease NCT01042977
完了結果公開
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes NCT01554618
完了結果公開
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58) NCT01730534
完了結果公開
Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy NCT03755934
中止結果公開
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease (PLANET II) NCT00296400
完了結果公開
Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease (MIRACLE) NCT04595370
完了結果公開
A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease NCT04492722
中止結果公開